Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: Building and retaining talented staff is critical to FDA’s ability to meet our public health mission. FDA is taking… https://t.co/sXlmgpOYSP
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: Building and retaining talented staff is critical to FDA’s ability to meet our public health mission. FDA takes new… https://t.co/2WXe6IwQSQ
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: Even though #generics & brand-name drugs may look different, they have the same key ingredients. Watch our full PSA… https://t.co/lXg5YQJN4s
SteveFDA (R-D.C.)
@SGottliebFDA
Today I’m announcing a comprehensive policy framework for the proper development and oversight of… https://t.co/TtWpoxuTJJ
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: (1/3) The new tools that Congress has authorized will give FDA the ability to prioritize the needs of warfighters f… https://t.co/8ipcrhQ6wv
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: (2/3) We’re working on a plan to implement these new pathways in a robust and expedited fashion, in order to quickl… https://t.co/NTlJij2gj5
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: (3/3) As commissioner, I’m personally committed to this effort. It’s one of my highest priorities. In collaboration… https://t.co/cmRkd14APa
SteveFDA (R-D.C.)
@SGottliebFDA
Appreciate @USDA @SecretarySonny commitment to have food safety focus lead US Codex work and look forward to contin… https://t.co/xM44FZhY1C
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: New guidance documents on #regenerativemedicine outline an efficient, science-based process for ensuring the safety… https://t.co/49UMwTvmAC
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SecretarySonny: Thank you, @SGottliebFDA. We will ensure Codex standards are grounded in science. https://t.co/EZkNU1REvg QT @SGottliebFDA: We support Secretary Purdue’s commitment to fulfilling the mission of Codex and look forward to working closely wit… https://t.co/oz7IVSdPvJ)
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA unveiled today its new, comprehensive framework for the oversight of cell-based regenerative medicine https://t.co/2vlw882BMg
SteveFDA (R-D.C.)
@SGottliebFDA
RT @endpts: FDA clears next-gen tumor sequencing test from Memorial Sloan Kettering https://t.co/OuZYVcSSjd #diagnostics #biotech
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA unveiled today its new, comprehensive framework for the oversight of cell-based regenerative medicine https://t.co/CraJUfHdn9
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA unveiled today its new, comprehensive framework for the oversight of cell-based regenerative medicine https://t.co/CraJUfHdn9
SteveFDA (R-D.C.)
@SGottliebFDA
My statement on efforts by #FDA to help stabilize medical products industry in Puerto Rico; steps we’re taking with… https://t.co/fMpysGEi8M
SteveFDA (R-D.C.)
@SGottliebFDA
RT @endpts: FDA clears next-gen tumor sequencing test from Memorial Sloan Kettering https://t.co/OuZYVcSSjd #diagnostics
SteveFDA (R-D.C.)
@SGottliebFDA
RT @HHSGov: #ICYMI https://t.co/U1tPa36fp7 QT @US_FDA: Today the FDA announced a comprehensive policy framework, which aims to spur development and access to innovative t… https://t.co/gpfKSgVCul)
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: Today #FDA announced a comprehensive policy framework that aims to spur development and access to innovative regene… https://t.co/SVFaUD0JP4
SteveFDA (R-D.C.)
@SGottliebFDA
RT @InfantCoalition: Especially important as today we recognize #WorldPrematurityDay2017 https://t.co/cYqDblz72l QT @SGottliebFDA: Despite efforts to ↑ number of FDA-approved therapies for children, 60% of drugs used in children not approved for… https://t.co/or305ef1eu)
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAOncology: FDA Voice by @FDAOncology Pazdur: In cancer treatment, there's more than one way to measure patient benefit… https://t.co/GR7aNGKwSi